Hantz Financial Services’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Sell
724
-2
-0.3% -$846 ﹤0.01% 965
2026
Q1
$344K Buy
726
+303
+72% +$153K 0.01% 793
2025
Q4
$197K Buy
423
+50
+13% +$23.2K ﹤0.01% 873
2025
Q3
$159K Sell
373
-13
-3% -$5.04K ﹤0.01% 820
2025
Q2
$148K Sell
386
-19,348
-98% -$6.97M ﹤0.01% 669
2025
Q1
$6.82M Buy
19,734
+1,694
+9% +$545K 0.12% 176
2024
Q4
$5.42M Buy
18,040
+2,621
+17% +$916K 0.09% 203
2024
Q3
$6.27M Buy
15,419
+139
+0.9% +$50.9K 0.11% 191
2024
Q2
$4.91M Sell
15,280
-110
-0.7% -$35.7K 0.09% 212
2024
Q1
$5.13M Sell
15,390
-4
-0% -$1.22K 0.1% 215
2023
Q4
$4.17M Buy
+15,394
New +$3.8M 0.09% 237
2020
Q3
Sell
-10
Closed -$1K 592
2020
Q2
$1K Buy
+10
New +$1.04K ﹤0.01% 545

Other funds holding HCA

Hantz Financial Services's HCA Position: Q2 2026 in Review

Hantz Financial Services reduced its HCA Healthcare (HCA) stake by 0.28% in Q2 2026, selling an estimated $846 and leaving 724 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

Hantz Financial Services first reported a position in HCA in Q2 2020 and has held it in 12 quarters since. The position peaked at $6.82M in Q1 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Hantz Financial Services held 724 shares of HCA Healthcare worth $282K as of Q2 2026.
  • Hantz Financial Services sold 2 HCA Healthcare shares in Q2 2026, an estimated $846.
  • HCA Healthcare made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #965 holding.
  • Hantz Financial Services first reported a position in HCA Healthcare in Q2 2020 and has held it in 12 quarters since.
  • Hantz Financial Services's HCA Healthcare position peaked at $6.82M in Q1 2025.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.